[SYRE] YoY Quarter Result on 31-Dec-2018 [#Q4]

Stock
[SYRE] Spyre Therapeutics, Inc.
Announcement Date
31-Dec-2018
Financial Year
2018
Quarter
31-Dec-2018 [#Q4]
Profit Trend
QoQ- -25.01%
YoY- -129.80%
Quarter Report
SYRE's Result
SYRE's Financial Summary
View:
Show?
Quarter Result
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Revenue 3,644 0 0 0 1,482 1,247 1,585 14.86%
PBT -20,423 -22,714 -21,495 -14,898 -6,483 -5,483 -3,987 31.26%
Tax 23 0 0 0 0 0 0 -
NP -20,446 -22,714 -21,495 -14,898 -6,483 -5,483 -3,987 31.28%
Tax Rate - - - - - - - -
Total Cost 24,090 22,714 21,495 14,898 7,965 6,730 5,572 27.60%
Ratio Analysis
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
NP Margin -561.09 0.00 0.00 0.00 -437.45 -439.70 -251.55 14.29%
Per Share
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
EPS -10.36 0.00 0.00 0.00 0.00 0.00 0.00 -
EPS Diluted -10.36 0.00 0.00 0.00 0.00 0.00 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.